YOUR BUSINESS AUTHORITY
Springfield, MO
St. Louis biotechnology startup Wugen Inc. raised $172 million in a funding round.
The company plans to use the funds to advance clinical development of its cancer-fighting therapies, the St. Louis Business Journal reports.
The startup has raised more than $200 million to date.
Read more from the St. Louis Business Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects